152 related articles for article (PubMed ID: 23034333)
1. MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme.
Lin J; Teo S; Lam DH; Jeyaseelan K; Wang S
Cell Death Dis; 2012 Oct; 3(10):e398. PubMed ID: 23034333
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b.
El Fatimy R; Subramanian S; Uhlmann EJ; Krichevsky AM
Mol Ther; 2017 Feb; 25(2):368-378. PubMed ID: 28153089
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway.
Wang Q; Cai J; Fang C; Yang C; Zhou J; Tan Y; Wang Y; Li Y; Meng X; Zhao K; Yi K; Zhang S; Zhang J; Jiang C; Zhang J; Kang C
Theranostics; 2018; 8(17):4733-4749. PubMed ID: 30279734
[No Abstract] [Full Text] [Related]
4. Inactivation of the ATMIN/ATM pathway protects against glioblastoma formation.
Blake SM; Stricker SH; Halavach H; Poetsch AR; Cresswell G; Kelly G; Kanu N; Marino S; Luscombe NM; Pollard SM; Behrens A
Elife; 2016 Mar; 5():. PubMed ID: 26984279
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy.
Shetty K; Yasaswi S; Dutt S; Yadav KS
3 Biotech; 2022 Nov; 12(11):301. PubMed ID: 36276454
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain.
Sabattini S; Baldassarro VA; Zaccone R; Calzà L; Giardino L; Vascellari M; Lorenzini L; Moretti M; Marconato L
Vet Comp Oncol; 2024 Mar; 22(1):70-77. PubMed ID: 38112225
[TBL] [Abstract][Full Text] [Related]
7. Glioma Induction by Intracerebral Retrovirus Injection.
Verma RK; Lu F; Lu QR
Bio Protoc; 2017 Jul; 7(14):e2404. PubMed ID: 34541135
[TBL] [Abstract][Full Text] [Related]
8. Tailored Lipoprotein-Like miRNA Delivery Nanostructure Suppresses Glioma Stemness and Drug Resistance through Receptor-Stimulated Macropinocytosis.
Jiang G; Chen H; Huang J; Song Q; Chen Y; Gu X; Jiang Z; Huang Y; Lin Y; Feng J; Jiang J; Bao Y; Zheng G; Chen J; Chen H; Gao X
Adv Sci (Weinh); 2020 Mar; 7(5):1903290. PubMed ID: 32154087
[TBL] [Abstract][Full Text] [Related]
9. Retracted: miRNA-448 Regulates the Development of Glioblastoma (GBM) by Regulating Rho-Associated Protein Kinase 1.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9843918. PubMed ID: 37946962
[TBL] [Abstract][Full Text] [Related]
10. A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival.
Kefas B; Floyd DH; Comeau L; Frisbee A; Dominguez C; Dipierro CG; Guessous F; Abounader R; Purow B
Neuro Oncol; 2013 Dec; 15(12):1652-63. PubMed ID: 24158111
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C
PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502
[TBL] [Abstract][Full Text] [Related]
12. Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide
Malhotra M; Sekar TV; Ananta JS; Devulapally R; Afjei R; Babikir HA; Paulmurugan R; Massoud TF
Oncotarget; 2018 Apr; 9(30):21478-21494. PubMed ID: 29765554
[TBL] [Abstract][Full Text] [Related]
13. Tailored Nanoparticle Codelivery of antimiR-21 and antimiR-10b Augments Glioblastoma Cell Kill by Temozolomide: Toward a "Personalized" Anti-microRNA Therapy.
Ananta JS; Paulmurugan R; Massoud TF
Mol Pharm; 2016 Sep; 13(9):3164-75. PubMed ID: 27508339
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells.
Ananta JS; Paulmurugan R; Massoud TF
Mol Pharm; 2015 Dec; 12(12):4509-17. PubMed ID: 26559642
[TBL] [Abstract][Full Text] [Related]
15. Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma.
Valle-Garcia D; Pérez de la Cruz V; Flores I; Salazar A; Pineda B; Meza-Sosa KF
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473710
[TBL] [Abstract][Full Text] [Related]
16. Engineered smart materials for RNA based molecular therapy to treat Glioblastoma.
Singh RR; Mondal I; Janjua T; Popat A; Kulshreshtha R
Bioact Mater; 2024 Mar; 33():396-423. PubMed ID: 38059120
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets-Recent Insights at Molecular and Cellular Level.
Poller W; Sahoo S; Hajjar R; Landmesser U; Krichevsky AM
Cells; 2023 Nov; 12(22):. PubMed ID: 37998395
[TBL] [Abstract][Full Text] [Related]
18. Limbal Epithelial Stem Cells in the Diabetic Cornea.
Nureen L; Di Girolamo N
Cells; 2023 Oct; 12(20):. PubMed ID: 37887302
[TBL] [Abstract][Full Text] [Related]
19. Methods of miRNA delivery and possibilities of their application in neuro-oncology.
Gareev I; Beylerli O; Tamrazov R; Ilyasova T; Shumadalova A; Du W; Yang B
Noncoding RNA Res; 2023 Dec; 8(4):661-674. PubMed ID: 37860265
[TBL] [Abstract][Full Text] [Related]
20. Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics.
Tabnak P; Hasanzade Bashkandi A; Ebrahimnezhad M; Soleimani M
Cancer Cell Int; 2023 Oct; 23(1):238. PubMed ID: 37821870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
